OBJECTIVE: To examine the association between high-risk patient status (age >75 years or Charlson comorbidity index count >2) and postoperative complications in patients undergoing surgical management for clinically localized renal tumors. MATERIALS AND METHODS: Patients undergoing radical nephrectomy (RN) or partial nephrectomy (PN) (2005-2012) for localized renal cell carcinoma were analyzed. Multivariate logistic regressions were used to test the association between high-risk status and postoperative complications adjusting for patient, tumor, and operative characteristics. RESULTS: Of 1092 patients undergoing PN (71.9%) or RN (28.1%) for clinically localized renal tumors, 255 (23.4%) were classified as high risk, and 175 patients (16%) developed at least 1 complication (mean 1.6 ± 1.0). Of note, 22.4% and 14.1% of high- and low-risk patients developed a complication, respectively (P = .002). Comparing high- and low-risk patients, significant differences in Clavien I-II (20.4% vs 11.1%; P <.001) and medical (16.1% vs 8.1%, P <.001) complications were observed, whereas no differences were seen in Clavien III-V or surgical complications. No differences in complications were observed comparing patients treated with RN and PN, albeit high-risk patients were more likely to undergo RN (35.3% vs 25.9%, P = .04). After adjustment, the odds of incurring any complication were 1.9 times higher in high- compared with low-risk patients (odds ratio 1.9 [confidence interval 1.3-2.8]). CONCLUSION: Regardless of surgical type, patients deemed high risk by age and comorbidity criteria were more likely to incur a postoperative complication after renal mass resection. Improved understanding of surgical risks in the elderly and infirmed will help better inform patients deciding between active surveillance and resection of renal tumors.
OBJECTIVE: To examine the association between high-risk patient status (age >75 years or Charlson comorbidity index count >2) and postoperative complications in patients undergoing surgical management for clinically localized renal tumors. MATERIALS AND METHODS:Patients undergoing radical nephrectomy (RN) or partial nephrectomy (PN) (2005-2012) for localized renal cell carcinoma were analyzed. Multivariate logistic regressions were used to test the association between high-risk status and postoperative complications adjusting for patient, tumor, and operative characteristics. RESULTS: Of 1092 patients undergoing PN (71.9%) or RN (28.1%) for clinically localized renal tumors, 255 (23.4%) were classified as high risk, and 175 patients (16%) developed at least 1 complication (mean 1.6 ± 1.0). Of note, 22.4% and 14.1% of high- and low-risk patients developed a complication, respectively (P = .002). Comparing high- and low-risk patients, significant differences in Clavien I-II (20.4% vs 11.1%; P <.001) and medical (16.1% vs 8.1%, P <.001) complications were observed, whereas no differences were seen in Clavien III-V or surgical complications. No differences in complications were observed comparing patients treated with RN and PN, albeit high-risk patients were more likely to undergo RN (35.3% vs 25.9%, P = .04). After adjustment, the odds of incurring any complication were 1.9 times higher in high- compared with low-risk patients (odds ratio 1.9 [confidence interval 1.3-2.8]). CONCLUSION: Regardless of surgical type, patients deemed high risk by age and comorbidity criteria were more likely to incur a postoperative complication after renal mass resection. Improved understanding of surgical risks in the elderly and infirmed will help better inform patients deciding between active surveillance and resection of renal tumors.
Authors: Christopher J Weight; David C Miller; Steven C Campbell; Ithaar H Derweesh; Brian R Lane; Edward M Messing Journal: J Urol Date: 2013-01-18 Impact factor: 7.450
Authors: Youssef S Tanagho; Jihad H Kaouk; Mohamad E Allaf; Craig G Rogers; Michael D Stifelman; Bartosz F Kaczmarek; Shahab P Hillyer; Jeffrey K Mullins; Yichun Chiu; Sam B Bhayani Journal: Urology Date: 2013-03 Impact factor: 2.649
Authors: Brian Shuch; Janet Hanley; Julie Lai; Srinivas Vourganti; Simon P Kim; Claude M Setodji; Andrew W Dick; Wong-Ho Chow; Chris Saigal Journal: Cancer Date: 2013-05-14 Impact factor: 6.860
Authors: Dharam Kaushik; Simon P Kim; M Adam Childs; Christine M Lohse; Brian A Costello; John C Cheville; Stephen A Boorjian; Bradley C Leibovich; R Houston Thompson Journal: Eur Urol Date: 2012-12-25 Impact factor: 20.096
Authors: Simon P Kim; Bradley C Leibovich; Nilay D Shah; Christopher J Weight; Bijan J Borah; Leona C Han; Stephen A Boorjian; R Houston Thompson Journal: BJU Int Date: 2012-05-07 Impact factor: 5.588
Authors: Alexander Kutikov; Brian L Egleston; Daniel Canter; Marc C Smaldone; Yu-Ning Wong; Robert G Uzzo Journal: J Urol Date: 2012-10-18 Impact factor: 7.450
Authors: Hiten D Patel; Phillip M Pierorazio; Michael H Johnson; Ritu Sharma; Emmanuel Iyoha; Mohamad E Allaf; Eric B Bass; Stephen M Sozio Journal: Clin J Am Soc Nephrol Date: 2017-05-08 Impact factor: 8.237
Authors: Rebecca L O'Malley; Matthew H Hayn; Katherine A Brewer; Willie Underwood; Nicholas J Hellenthal; Hyung L Kim; Igor Sorokin; Thomas Schwaab Journal: World J Urol Date: 2015-03-25 Impact factor: 4.226
Authors: Kenan E Celtik; Paras H Shah; Vinay R Patel; Daniel M Moreira; Arvin K George; Valerio Iacovelli; Manaf Alom; Andrew Ng; Amin Herati; Simpa S Salami; Hannah Bierwiler; Michael J Schwartz; Lee Richstone; Joph Steckel; Manish A Vira; Louis R Kavoussi Journal: World J Urol Date: 2016-11-01 Impact factor: 4.226
Authors: Matthew D Grimes; Michael L Blute; Tyler A Wittmann; Michael A Mann; Kristin Zorn; Tracy M Downs; Fangfang Shi; David F Jarrard; Sara L Best; Kyle A Richards; Stephen Y Nakada; E Jason Abel Journal: Urology Date: 2016-06-23 Impact factor: 2.649
Authors: Johannes Uhlig; Arne Strauss; Gerta Rücker; Ali Seif Amir Hosseini; Joachim Lotz; Lutz Trojan; Hyun S Kim; Annemarie Uhlig Journal: Eur Radiol Date: 2018-09-25 Impact factor: 5.315
Authors: Jeffrey J Tomaszewski; Marc C Smaldone; Bic Cung; Tianyu Li; Reza Mehrazin; Alexander Kutikov; Daniel J Canter; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo Journal: Urology Date: 2014-06-26 Impact factor: 2.649